feeling weak on semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. βΈ» π‘ Common Ozempic (semaglutide) is commonly used
Description
Patients who experience nausea, vomiting, or diarrhea that leads to dehydration may be at higher risk for kidney issues
Deng et al

Metabolic adaptationwhere your body resists further weight loss over timeaffects many patients

The GLP-1 receptor/GIP receptor/GCGR triple agonist efocipegtrutide is presently under investigation in individuals with MASLD, and preclinical accounts of other dual and triple agonists that include GLP-1 receptor and GCGR agonism suggest that clinical studies in individuals with type 2 diabetes will follow [62, 63]
